The impact of social isolation on aging health in schizophrenia
社会隔离对精神分裂症老年健康的影响
基本信息
- 批准号:10680522
- 负责人:
- 金额:$ 64.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgeAge YearsAgingAntipsychotic AgentsBehaviorBiological MarkersBody mass indexCOVID-19COVID-19 pandemicCharacteristicsClinicalCognitionCountryDataDepressed moodDiagnosisDietDiseaseElderlyEnvironmentEthnic OriginEthnic PopulationEuropeExhibitsGeneral PopulationGoalsGovernmentHealthIndividualLifeLonelinessLongevityMeasuresMedicalMedical RecordsMental DepressionNatural experimentOutcomeParticipantPatientsPatternPhenotypePhysically ChallengedPhysiciansPremature MortalityPreventiveProcessPsychotic DisordersRaceResearchResourcesRiskRisk FactorsRisk ReductionSchizophreniaSeverity of illnessSiblingsSmokeSmokingSocial NetworkSocial isolationSocializationStressSubgroupSymptomsTestingTimeUnhealthy DietVulnerable PopulationsWorkage relatedcohortcomorbiditycoronavirus diseasedesigndigitalfollow-uphealth datahealth differencehuman old age (65+)longitudinal databaselongitudinal designmedical examinationmiddle agemortalityneuropsychiatryphysical conditioningphysical inactivitypoor health outcomepost-pandemicprematurepreventracial populationsecondary analysissexsocial contactsymptomatologytargeted treatmentunhealthy lifestyle
项目摘要
PROJECT SUMMARY
Individuals diagnosed with schizophrenia and related psychotic disorders (SZ) exhibit a markedly elevated risk
of premature mortality, with a 10–20-year shorter lifespan relative to the general population. Increased mortality
rates in SZ are largely attributable to the early manifestation of medical conditions that normally occur later in
life, a process known as ‘accelerated aging’. While unhealthy lifestyle behaviors, such as smoking and unhealthy
diet, account, in part, for accelerated aging in SZ, the excess of physical comorbidities cannot be solely attributed
to these factors. Remarkably, the direct adverse health effects of key clinical characteristics of SZ have rarely
been considered. In the general population, the absence of social contact is known to pose enormous challenges
for physical health, especially at older ages. Given that social isolation is a persistent and disabling feature of
SZ, it is possible that this behavior may contribute to the premature manifestation of health conditions in SZ.
Building on rich pilot data pointing to significant associations between social isolation and long-term perceived
health in SZ, our overarching goal is to test whether and how social isolation contributes to the health
challenges of individuals with SZ as they age. With participants from Europe (EU-GEI) and the US (Olin
Neuropsychiatry Research Center), we will create a longitudinal database of 650 participants, including 500
individuals with SZ, and 150 of their unaffected siblings. We will apply an accelerated longitudinal design by re-
assessing and by examining medical records of research participants who were first evaluated between the
ages of 30-50 and are now 50-65 years of age, a period when many medical conditions and health problems
tend to manifest. We will determine the age-related association between social isolation and adverse health
outcomes in SZ, test for familiality, directionality, and factors moderating this association, and determine the
extent to which the COVID-19 pandemic and the resulting imposed lockdowns impacted health in SZ. We will
consider generalizability across countries, sexes, and race/ethnicities. The rationale for the proposed research
is that in order to facilitate much-needed targeted therapies to prevent early mortality in SZ, we need to better
understand factors that contribute to the excess of medical comorbidities in SZ. Our central hypothesis is that
social isolation, a common and persistent characteristic of SZ, contributes to the excess of physical
comorbidities in SZ. To meet our overall goal, we will pursue the following aims: (1) Determine the association
between social isolation and adverse health outcomes in SZ; (2) Test for the directionality, and moderating
factors, of the association between social isolation and health outcomes in SZ, and; (3) Examine whether the
COVID-19 pandemic modified associations between social isolation and health outcome in SZ. This study will
be the first to comprehensively examine the health impact of social isolation in SZ. The project may show that
in SZ socialization in midlife can reduce the risk for poor health outcomes and ultimately facilitate much-needed
preventive targeted therapies to reduce early-age mortality in SZ.
项目概要
被诊断患有精神分裂症和相关精神病 (SZ) 的个体表现出明显升高的风险
过早死亡,与一般人群相比,寿命缩短 10-20 年。
深圳的发病率很大程度上归因于通常在晚些时候出现的医疗状况的早期表现
生活中,一个被称为“加速衰老”的过程是不健康的生活方式,例如吸烟和不健康的行为。
饮食,在一定程度上是深圳加速衰老的原因,过多的身体合并症不能仅仅归因于
值得注意的是,SZ 的关键临床特征很少对健康产生直接的不良影响。
对于普通人群来说,缺乏社会接触会带来巨大的挑战。
对于身体健康,尤其是老年人来说,社会孤立是一个持续存在的、令人丧失能力的特征。
SZ,这种行为可能会导致 SZ 的健康状况过早显现。
丰富的试点数据表明社会孤立与长期感知之间存在显着关联
深圳的健康,我们的首要目标是测试社会隔离是否以及如何影响健康
来自欧洲 (EU-GEI) 和美国 (Olin) 的参与者随着年龄的增长而面临的挑战。
神经精神病学研究中心),我们将创建一个包含 650 名参与者的纵向数据库,其中 500
患有 SZ 的个体及其 150 名未受影响的加速兄弟姐妹我们将通过重新应用纵向设计。
评估并检查研究参与者的医疗记录,这些参与者在
30-50岁和现在的50-65岁,这个时期是许多医疗状况和健康问题的时期
我们将确定社会孤立与不良健康之间的年龄相关性。
SZ 的结果,测试熟悉度、方向性和调节这种关联的因素,并确定
COVID-19 大流行以及由此产生的封锁对深圳健康的影响程度我们将予以关注。
考虑跨国家、性别和种族/民族的普遍性 拟议研究的基本原理。
是为了促进急需的靶向治疗以预防深圳的早期死亡,我们需要更好地
了解导致深圳出现过多医疗合并症的因素 我们的中心假设是:
社会孤立是深圳的一个普遍且持久的特征,导致身体活动过度
为了实现我们的总体目标,我们将追求以下目标: (1) 确定关联。
深圳的社会隔离与不良健康结果之间的关系;(2)测试方向性和调节性
深圳的社会孤立与健康结果之间的关联因素,以及 (3) 检查是否
COVID-19 大流行改变了深圳的社会隔离与健康结果之间的关联。
成为第一个全面研究深圳社会隔离对健康影响的项目。
在深圳,中年社会化可以降低不良健康结果的风险,并最终促进急需的
预防性靶向治疗可降低深圳的早期死亡率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ABRAHAM REICHENBERG其他文献
ABRAHAM REICHENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ABRAHAM REICHENBERG', 18)}}的其他基金
The impact of social isolation on aging health in schizophrenia
社会隔离对精神分裂症老年健康的影响
- 批准号:
10522303 - 财政年份:2022
- 资助金额:
$ 64.44万 - 项目类别:
The impact of social isolation on aging health in schizophrenia
社会隔离对精神分裂症老年健康的影响
- 批准号:
10522303 - 财政年份:2022
- 资助金额:
$ 64.44万 - 项目类别:
Autism and Prenatal Endocrine Disruptors (A-PED)
自闭症和产前内分泌干扰物 (A-PED)
- 批准号:
10251532 - 财政年份:2021
- 资助金额:
$ 64.44万 - 项目类别:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
自闭症风险与母亲心脏代谢健康 (ARCH) 研究
- 批准号:
10443600 - 财政年份:2019
- 资助金额:
$ 64.44万 - 项目类别:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
自闭症风险与母亲心脏代谢健康 (ARCH) 研究
- 批准号:
10674627 - 财政年份:2019
- 资助金额:
$ 64.44万 - 项目类别:
Autism Risk and Maternal Cardiometabolic Health (ARCH) study
自闭症风险与母亲心脏代谢健康 (ARCH) 研究
- 批准号:
10178066 - 财政年份:2019
- 资助金额:
$ 64.44万 - 项目类别:
Autism and Prenatal Endocrine Disruptors (A-PED)
自闭症和产前内分泌干扰物 (A-PED)
- 批准号:
9133065 - 财政年份:2016
- 资助金额:
$ 64.44万 - 项目类别:
Autism and Prenatal Endocrine Disruptors (A-PED)
自闭症和产前内分泌干扰物 (A-PED)
- 批准号:
9349499 - 财政年份:2016
- 资助金额:
$ 64.44万 - 项目类别:
Autism and Prenatal Endocrine Disruptors (A-PED)
自闭症和产前内分泌干扰物 (A-PED)
- 批准号:
10006730 - 财政年份:2016
- 资助金额:
$ 64.44万 - 项目类别:
Multigenerational FamIlial and Environmental Risk for Autism (MINERvA) Network
自闭症多代家庭和环境风险 (MINERvA) 网络
- 批准号:
8537788 - 财政年份:2012
- 资助金额:
$ 64.44万 - 项目类别:
相似国自然基金
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
GNAS介导OPN4-PLCβ4-TRPC6/7通路调节自主感光视网膜神经节细胞在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301229
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Regulation of Vascular Calcification by Adventitial Endothelial Cells
外膜内皮细胞对血管钙化的调节
- 批准号:
10642619 - 财政年份:2023
- 资助金额:
$ 64.44万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 64.44万 - 项目类别:
Identifying and understanding the role of repeat RNAs and RAN proteins in Alzheimer's disease
识别和理解重复 RNA 和 RAN 蛋白在阿尔茨海默病中的作用
- 批准号:
10833734 - 财政年份:2023
- 资助金额:
$ 64.44万 - 项目类别:
Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami
预测撒哈拉以南非洲艾滋病毒流行率的年龄变化:应对银色海啸的必要流行病学步骤
- 批准号:
10762075 - 财政年份:2023
- 资助金额:
$ 64.44万 - 项目类别:
Virus and olfactory system interactions accelerate Alzheimer's disease pathology
病毒和嗅觉系统相互作用加速阿尔茨海默病病理学
- 批准号:
10669880 - 财政年份:2023
- 资助金额:
$ 64.44万 - 项目类别: